Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,576.81
(
-0.72%
)
US TECH 100
23,597.60
(
-0.83%
)
Dow Jones
45,814.19
(
-0.89%
)
Brent Oil
105.43
(
-1.08%
)
Bitcoin
69,699.44
(
-2.16%
)
News Focus
News Focus
Post# of 257259
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 97527

Monday, 06/21/2010 10:49:49 AM

Monday, June 21, 2010 10:49:49 AM

Post# of 257259
Re Oppenheimer MS survey

73% of neurologists thought use of Copaxone could
decrease. On ave. Copaxone use could decline by 18.6% if gilenia is approved. They estimate Teva's 2011 EPS could drop 6.5% if gilenia is approved.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up